Lobe Sciences Ltd. (LOBE.CN)
CAD 0.02
(-42.86%)
CAD 0.02
(-42.86%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.45 Million CAD | 88.91% |
| 2022 | 1.3 Million CAD | 61.8% |
| 2021 | 804.7 Thousand CAD | -10.3% |
| 2020 | 897.08 Thousand CAD | 70.04% |
| 2019 | 527.55 Thousand CAD | 299.42% |
| 2018 | 132.08 Thousand CAD | 1896.4% |
| 2017 | 6616.00 CAD | 3.44% |
| 2016 | 6396.00 CAD | 6.6% |
| 2015 | 6000.00 CAD | -12.32% |
| 2014 | 6843.00 CAD | 9.0% |
| 2013 | 6278.00 CAD | -43.87% |
| 2012 | 11.18 Thousand CAD | -65.52% |
| 2011 | 32.43 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.87 Million CAD | 16.72% |
| 2024 Q3 | 3.07 Million CAD | -8.07% |
| 2024 Q2 | 3.34 Million CAD | 16.46% |
| 2023 Q1 | 1.43 Million CAD | 10.34% |
| 2023 Q2 | 1.98 Million CAD | 38.36% |
| 2023 Q4 | 2.45 Million CAD | -1.12% |
| 2023 Q3 | 2.48 Million CAD | 25.14% |
| 2023 FY | 2.45 Million CAD | 88.91% |
| 2022 FY | 1.3 Million CAD | 61.8% |
| 2022 Q1 | 1.1 Million CAD | 37.48% |
| 2022 Q4 | 1.3 Million CAD | 21.79% |
| 2022 Q3 | 1.06 Million CAD | -15.64% |
| 2022 Q2 | 1.26 Million CAD | 14.55% |
| 2021 Q2 | 456.77 Thousand CAD | 3.5% |
| 2021 Q3 | 1.18 Million CAD | 159.39% |
| 2021 FY | 804.7 Thousand CAD | -10.3% |
| 2021 Q4 | 804.7 Thousand CAD | -32.08% |
| 2021 Q1 | 441.31 Thousand CAD | -50.81% |
| 2020 Q1 | 903.12 Thousand CAD | 71.19% |
| 2020 FY | 897.08 Thousand CAD | 70.04% |
| 2020 Q2 | 837.75 Thousand CAD | -7.24% |
| 2020 Q4 | 897.08 Thousand CAD | 5.74% |
| 2020 Q3 | 848.36 Thousand CAD | 1.27% |
| 2019 Q2 | 181.44 Thousand CAD | 37.38% |
| 2019 FY | 527.55 Thousand CAD | 299.42% |
| 2019 Q3 | 249.21 Thousand CAD | 37.35% |
| 2019 Q4 | 527.55 Thousand CAD | 111.69% |
| 2019 Q1 | 132.08 Thousand CAD | 648.04% |
| 2018 Q2 | 8033.00 CAD | 21.42% |
| 2018 Q1 | 6616.00 CAD | 0.0% |
| 2018 FY | 132.08 Thousand CAD | 1896.4% |
| 2018 Q3 | 8042.00 CAD | 0.11% |
| 2018 Q4 | 17.65 Thousand CAD | 119.56% |
| 2017 Q4 | - CAD | -100.0% |
| 2017 FY | 6616.00 CAD | 3.44% |
| 2017 Q3 | 7056.00 CAD | 17.6% |
| 2017 Q2 | 6000.00 CAD | -6.19% |
| 2017 Q1 | 6396.00 CAD | 0.0% |
| 2016 FY | 6396.00 CAD | 6.6% |
| 2016 Q2 | 8033.00 CAD | 33.88% |
| 2016 Q4 | - CAD | -100.0% |
| 2016 Q3 | 402.00 CAD | -95.0% |
| 2016 Q1 | 6000.00 CAD | 0.0% |
| 2015 FY | 6000.00 CAD | -12.32% |
| 2015 Q4 | - CAD | -100.0% |
| 2015 Q3 | 350.00 CAD | -73.12% |
| 2015 Q2 | 1302.00 CAD | -80.97% |
| 2015 Q1 | 6843.00 CAD | 2343.93% |
| 2014 Q3 | 2322.00 CAD | -63.03% |
| 2014 Q1 | 6278.00 CAD | 1109.63% |
| 2014 FY | 6843.00 CAD | 9.0% |
| 2014 Q2 | 6281.00 CAD | 0.05% |
| 2014 Q4 | 280.00 CAD | -87.94% |
| 2013 Q3 | 9015.00 CAD | -23.47% |
| 2013 Q1 | 11.18 Thousand CAD | 1047.18% |
| 2013 Q2 | 11.78 Thousand CAD | 5.32% |
| 2013 Q4 | 519.00 CAD | -94.24% |
| 2013 FY | 6278.00 CAD | -43.87% |
| 2012 Q2 | 14.02 Thousand CAD | -56.75% |
| 2012 FY | 11.18 Thousand CAD | -65.52% |
| 2012 Q1 | 32.43 Thousand CAD | 0.0% |
| 2012 Q3 | - CAD | -100.0% |
| 2012 Q4 | 975.00 CAD | 0.0% |
| 2011 FY | 32.43 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | 16.24% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | 82.823% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -422.519% |
| The BC Bud Corporation | 626 Thousand CAD | -292.908% |
| BioNxt Solutions Inc. | 6.55 Million CAD | 62.45% |
| CordovaCann Corp. | 11.29 Million CAD | 78.216% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | 71.067% |
| Captor Capital Corp. | 28.76 Million CAD | 91.449% |
| City View Green Holdings Inc. | 3.73 Million CAD | 34.111% |
| 1CM Inc. | 9.42 Million CAD | 73.9% |
| Global Hemp Group Inc. | 5.82 Million CAD | 57.776% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 88.384% |
| IM Cannabis Corp. | 35.11 Million CAD | 92.995% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | 75.601% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -853.34% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | 44.142% |
| Ovation Science Inc. | 728.99 Thousand CAD | -237.4% |
| Pharmadrug Inc. | 2.92 Million CAD | 15.924% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | -17.744% |
| RAMM Pharma Corp. | 2.83 Million CAD | 13.257% |
| RIV Capital Inc. | 275.63 Million CAD | 99.108% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | 27.742% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 99.325% |
| SLANG Worldwide Inc. | 37.58 Million CAD | 93.455% |
| 1933 Industries Inc. | 23.28 Million CAD | 89.436% |
| Red Light Holland Corp. | 3.82 Million CAD | 35.64% |
| Top Strike Resources Corp. | 20.99 Million CAD | 88.284% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | -211.362% |
| Adastra Holdings Ltd. | 17.65 Million CAD | 86.071% |